Defragmenting Data for the Future of Pharma R&D
Defragmenting data will enable you to ask the right questions, using all of your data, whether internal or external, clinical or real-world evidence (RWE) to bring about innovation and accelerate time-to-insight.
Insights from this white paper include:
- Create more efficient and effective R&D in a world without data silos
- Avoid data swamps – how to ensure intelligent database design for agile use of your data asset
- Understand solutions to increase internal and external data integration, and causes of the current defragmented system
- How to enact an organisation-wide approach to data and an IT architecture that enables this
Defragmenting Data for the Future of Pharma R&D white paper includes insights from Janssen, Sanofi, MarkLogic, Boehringer and AbbVie.
Please subscribe to view the analysis report